Skip to main content
Top
Published in:

09-07-2022 | Allergic Contact Dermatitis | Contact Dermatitis (B Adler and V Deleo, Section editors)

Psychological Considerations in Patients Undergoing Patch Testing

Authors: Erica L. Aukerman, JiaDe Yu, Katlein França

Published in: Current Dermatology Reports | Issue 3/2022

Login to get access

Abstract

Purpose of Review

Patch testing is the gold standard evaluation for allergic contact dermatitis, but there are important psychological considerations to be aware of. This review provides a stepwise, holistic approach for addressing patients who present for patch testing.

Recent Findings

It is important to clarify expectations prior to patch testing to mitigate potential disappointment as well as counsel patients on other possible conditions that mimic allergic contact dermatitis. Often, clinical severity does not correlate with the degree to which patients are psychologically distressed by their condition. Common comorbidities, including anxiety and depression, may warrant a psychological referral.

Summary

Patients who present to patch test clinics may benefit from focused psychosocial intervention. Understanding which patients are at high risk for psychological morbidity allows you for stratification to determine the need for referral to appropriate support services. It is important to acknowledge the effect that allergic contact dermatitis and related conditions can have on quality-of-life and speak with patients openly about how their condition has impacted them.
Literature
1.
go back to reference Picardi A, Abeni D. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143(5):983–91.CrossRef Picardi A, Abeni D. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143(5):983–91.CrossRef
2.
go back to reference Scalf LA, Genebriera J, et al. Patients’ perceptions of the usefulness and outcome of patch testing. J Am Acad Derm. 2007;56(6):928–32.CrossRef Scalf LA, Genebriera J, et al. Patients’ perceptions of the usefulness and outcome of patch testing. J Am Acad Derm. 2007;56(6):928–32.CrossRef
4.
go back to reference Kadyk DL, Hall S, Belsito DV. Quality of life of patients with allergic contact dermatitis: an exploratory analysis by gender, ethnicity, age, and occupation. Dermatitis. 2004;15(3):117–24.CrossRef Kadyk DL, Hall S, Belsito DV. Quality of life of patients with allergic contact dermatitis: an exploratory analysis by gender, ethnicity, age, and occupation. Dermatitis. 2004;15(3):117–24.CrossRef
5.
go back to reference Marron SE, Tomas-Aragones L, et al. The psychosocial burden of hand eczema: data from a European dermatological multicentre study. Contact Dermatitis. 2018;78(6):406–12.CrossRef Marron SE, Tomas-Aragones L, et al. The psychosocial burden of hand eczema: data from a European dermatological multicentre study. Contact Dermatitis. 2018;78(6):406–12.CrossRef
6.
go back to reference Bains SN, Nash P, Fonacier L. Irritant Contact Dermatitis. Clinic Rev Allerg Immunol. 2019;56:99–109.CrossRef Bains SN, Nash P, Fonacier L. Irritant Contact Dermatitis. Clinic Rev Allerg Immunol. 2019;56:99–109.CrossRef
7.
go back to reference Do LHD, Azizi N, et al. Sensitive skin syndrome: an update. Am J Clin Dermatol. 2020;21(3):401–9.CrossRef Do LHD, Azizi N, et al. Sensitive skin syndrome: an update. Am J Clin Dermatol. 2020;21(3):401–9.CrossRef
8.
go back to reference Wright RJ, Cohen RT, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol. 2005;5(1):23–9.CrossRef Wright RJ, Cohen RT, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol. 2005;5(1):23–9.CrossRef
9.
go back to reference Yuksel YT, Norreslet LB, et al. Allergic contact dermatitis in patients with atopic dermatitis. Curr Derm Rep. 2021;10:67–76.CrossRef Yuksel YT, Norreslet LB, et al. Allergic contact dermatitis in patients with atopic dermatitis. Curr Derm Rep. 2021;10:67–76.CrossRef
10.
go back to reference Gilhooley E, O’Grady C, Roche D, et al. High levels of psychological distress, sleep disturbance, and alcohol use disorder in adults with atopic dermatitis. Dermatitis. 2021;32(1S):S33–8.CrossRef Gilhooley E, O’Grady C, Roche D, et al. High levels of psychological distress, sleep disturbance, and alcohol use disorder in adults with atopic dermatitis. Dermatitis. 2021;32(1S):S33–8.CrossRef
11.
go back to reference Ronnstad A, Halling-Overgaard AS, et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis. J Am Acad Derm. 2018;79(3):448–56.CrossRef Ronnstad A, Halling-Overgaard AS, et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis. J Am Acad Derm. 2018;79(3):448–56.CrossRef
12.
go back to reference Engin B, Uguz F, Yilmaz E, et al. The levels of depression, anxiety, and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2008;22(1):36–40.PubMed Engin B, Uguz F, Yilmaz E, et al. The levels of depression, anxiety, and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2008;22(1):36–40.PubMed
13.
go back to reference Powell A, Nelson K, et al. Burning mouth syndrome and contact dermatitis. Dermatitis. 2020;31(4):238–43.CrossRef Powell A, Nelson K, et al. Burning mouth syndrome and contact dermatitis. Dermatitis. 2020;31(4):238–43.CrossRef
14.
go back to reference Pigatto P, Berti E, et al. Exfoliative cheilitis associated with titanium dental implants and mercury amalgam. J Dermatol Case Rep. 2011;5(4):89–90.CrossRef Pigatto P, Berti E, et al. Exfoliative cheilitis associated with titanium dental implants and mercury amalgam. J Dermatol Case Rep. 2011;5(4):89–90.CrossRef
15.
go back to reference Daley TD, Gupta AK. Exfoliative cheilitis. J Oral Pathol Med. 1995;24(4):177–9.CrossRef Daley TD, Gupta AK. Exfoliative cheilitis. J Oral Pathol Med. 1995;24(4):177–9.CrossRef
16.
go back to reference Raffi J, Elaine AI, Botto N. Validating responsiveness of a quality-of-life instrument for allergic contact dermatitis. Dermatitis. 2020;31(3):209–14.CrossRef Raffi J, Elaine AI, Botto N. Validating responsiveness of a quality-of-life instrument for allergic contact dermatitis. Dermatitis. 2020;31(3):209–14.CrossRef
17.
go back to reference Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003:1:29. Published online. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003:1:29. Published online.
18.
go back to reference Szabó Á, Brodszky V, Rencz FA. comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16. Br J Dermatol. 2021: Advance online publication. Szabó Á, Brodszky V, Rencz FA. comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16. Br J Dermatol. 2021: Advance online publication.
19.
go back to reference Kalboussi H, Kacem I, et al. Impact of allergic contact dermatitis on the quality of life and work productivity. Dermatol Res Pract 2019:3797536. eCollection. Kalboussi H, Kacem I, et al. Impact of allergic contact dermatitis on the quality of life and work productivity. Dermatol Res Pract 2019:3797536. eCollection.
20.
go back to reference Chren M. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30:231–6.CrossRef Chren M. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30:231–6.CrossRef
21.
go back to reference Heisterberg MV, Menne T, Johansen JD. Fragrance allergy and quality of life – development and validation of a disease-specific quality of life instrument. Contact Dermatitis. 2014;70(2):69–80.CrossRef Heisterberg MV, Menne T, Johansen JD. Fragrance allergy and quality of life – development and validation of a disease-specific quality of life instrument. Contact Dermatitis. 2014;70(2):69–80.CrossRef
Metadata
Title
Psychological Considerations in Patients Undergoing Patch Testing
Authors
Erica L. Aukerman
JiaDe Yu
Katlein França
Publication date
09-07-2022
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 3/2022
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-022-00362-9